Chong Kun Dang’s CKD-339 Enters Phase 3 in South Korea for Patients Uncontrolled on Monotherapy
CKD-339, an essential hypertension treatment under development by Chong Kun Dang, is advancing into a Phase 3 clinical trial in South Korea.
Search results for "hypertension treatment"
4 Things Older Adults Must Check Before Getting Dental Implants
Concerns over the safety of dental implants for older adults are rising following a series of fatal incidents at a dental clinic in Seoul’s Gangnam...
Stopping Beta-Blockers After Heart Attack Safe for Stable Patients, Korea-France Study Finds
One medication many patients take long-term following a heart attack is a beta-blocker.
550 Days in Limbo: Groups Demand 100-Day Fast-Track Insurance Coverage for Breakthrough PAH Drug Winrevair
With national health insurance coverage for the new pulmonary arterial hypertension treatment Winrevair (active...
Heavy Heatwave Risk: Why High Blood Pressure Patients Should Reach for Water, Not Naengmyeon Broth
As extreme heat continues across South Korea, with Seoul’s daytime high forecast to hit 39°C on August 7—Ipchu, the...
Life-Saving Heart Surgeries Give Four Kyrgyz Children a Fresh Start in South Korea
A seven-month-old infant who faced a life-threatening crisis without urgent intervention by the end of the year has...
Beyond Seoul: How a Secondary Hospital in Busan Mastered 167 Incompatible Kidney Transplants
When a family member steps forward to donate a kidney to a loved one suffering from end-stage renal disease, a blood...
Sudden Arm Weakness After Breast Cancer Diagnosis? Ischemic Stroke Risk Spikes 2.9-Fold in First Three Months
If you experience sudden weakness in an arm or leg, facial drooping, or slurred speech shortly after a breast cancer...
Novo Nordisk Secures EU Green Light for Oral Wegovy, Outpacing Eli Lilly in the Pill Market
The glucagon-like peptide-1 (GLP-1) obesity treatment market, long dominated by subcutaneous injections, is rapidly...
United Therapeutics Acquires Thymmune, Betting 460 Billion Won on Thymus Cell Therapy
The race to develop regenerative cell therapies for an ultra-rare disease that leaves patients born without a...